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Key points
 Depletion of Ca2+ stores activates store-operated channels (SOCs), which mediate Ca2+ entry
pathways that regulate cellular processes such as contraction, proliferation and gene expression.
 In vascular smooth muscle cells (VSMCs), stimulation of SOCs composed of canonical
transient receptor potential channel 1 (TRPC1) proteins requires G protein α q subunit
(Gαq)/phospholipase C (PLC)β1/protein kinase C (PKC) activity. We studied the role of
stromal interaction molecule 1 (STIM1) in coupling store depletion to this activation pathway
using patch clamp recording, GFP-PLCδ1-PH imaging and co-localization techniques.
 Store-operated TRPC1 channel and PLCβ1 activities were inhibited by STIM1 short hairpin
RNA (shRNA) and absent in TRPC1−/− cells, and store-operated PKC phosphorylation of
TRPC1 was inhibited by STIM1 shRNA. Store depletion induced interactions between STIM1
andTRPC1,Gαq andPLCβ1,which required STIM1andTRPC1. Similar effectswere produced
with noradrenaline.
 These findings identify a new activation mechanism of TRPC1-based SOCs in VSMCs,
and a novel role for STIM1, where store-operated STIM1-TRPC1 interactions stimulate
Gαq/PLCβ1/PKC activity to induce channel gating.
Abstract In vascular smooth muscle cells (VSMCs), stimulation of canonical transient receptor
potential channel 1 (TRPC1) protein-based store-operated channels (SOCs) mediates Ca2+
entry pathways that regulate contractility, proliferation and migration. It is therefore important
to understand how these channels are activated. Studies have shown that stimulation of
TRPC1-based SOCs requiresGproteinαq subunit (Gαq)/phospholipaseC (PLC)β1 activities and
protein kinase C (PKC) phosphorylation, although it is unclear how store depletion stimulates
this gating pathway. The present study examines this issue by focusing on the role of stromal
interaction molecule 1 (STIM1), an endo/sarcoplasmic reticulum Ca2+ sensor. Store-operated
TRPC1 channel activity was inhibited by TRPC1 and STIM1 antibodies and STIM1 short hairpin
RNA (shRNA) in wild-type VSMCs, and was absent in TRPC1−/− VSMCs. Store-operated PKC
phosphorylation of TRPC1 was reduced by knockdown of STIM1. Moreover, store-operated
PLCβ1 activity measured with the fluorescent phosphatidylinositol 4,5-bisphosphate/inositol
1,4,5-trisphosphate biosensor GFP-PLCδ1-PH was reduced by STIM1 shRNA and absent in
TRPC1−/− cells. Immunocytochemistry, co-immunoprecipitation and proximity ligation assays
revealed that store depletion activated STIM1 translocation from within the cell to the plasma
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membrane (PM) where it formed STIM1-TRPC1 complexes, which then associated with Gαq
and PLCβ1. Noradrenaline also evoked TRPC1 channel activity and associations between TRPC1,
STIM1, Gαq and PLCβ1, which were inhibited by STIM1 knockdown. Effects of N-terminal and
C-terminal STIM1 antibodies on TRPC1-based SOCs and STIM1 staining suggest that channel
activation may involve insertion of STIM1 into the PM. The findings of the present study identify
a new activation mechanism of TRPC1-based SOCs in VSMCs, and a novel role for STIM1,
in which store-operated STIM1-TRPC1 interactions stimulate PLCβ1 activity to induce PKC
phosphorylation of TRPC1 and channel gating.
(Resubmitted 15 September 2016; accepted after revision 13 October 2016; first published online 18 October 2016)
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Introduction
Ca2+-permeable store-operated channels (SOCs) are
physiologically activated by stimulation of the classical
phosphoinositol signalling pathway involving G protein
α q subunit (Gαq)-coupled receptors, phospholipase C
(PLC) activation, phosphatidylinositol 4,5-bisphosphate
(PIP2) hydrolysis, inositol 1,4,5-trisphosphate (InsP3)
generation and InsP3-mediated depletion of endo/
sarcoplasmic reticulum (ER/SR) Ca2+ stores. In vascular
smooth muscle cells (VSMCs), SOCs mediate Ca2+
entry pathways that regulate cellular functions such
as contractility, proliferation and migration, and are
potential therapeutic targets for cardiovascular diseases
such as hypertension and atherosclerosis (Abramowitz
& Birnbaumer, 2009; Beech, 2013; Earley & Brayden,
2015). Identifying the molecules involved in composing
and activating SOCs is an important objective in vascular
biology.
There is increasing evidence that cells express
two distinct types of SOCs (Cheng et al. 2013).
Prototypical SOCs, termed calcium release-activated
channels (CRACs) responsible for the calcium release
activated current (Icrac), have several characteristic
properties, such as high Ca2+ permeability, pronounced
inward rectification and unitary conductances in the
fS range, and are composed of pore-forming Orai1
proteins (Prakriya & Lewis, 2015). Orai1-based CRACs
are gated by store depletion through stromal inter-
action molecule 1 (STIM1), a Ca2+ sensor within
ER/SR stores that undergoes oligomerization after store
depletion and approaches the cytosolic surface of the
plasma membrane (PM) where it interacts directly with
Orai1 to induce channel opening (Prakriya & Lewis,
2015; Soboloff et al. 2012). It is also apparent that
many cell types express SOCs that have very different
properties to those of Orai1-based CRACs, such as much
lower Ca2+ permeability, relatively linear rectification and
considerably larger unitary conductances, and they are
proposed to be composed by the canonical transient
receptor potential family of Ca2+-permeable non-selective
cation channels (TRPC1–C7) (Cheng et al. 2013). It
is relatively well-accepted that TRPC1 are regulated by
store depletion, although there is less evidence for the
other channel subtypes. TRPC-based SOCs probably
form a diverse family of structures as TRPC subunits
form heteromeric channels (Alfonso et al. 2008; Saleh
et al. 2008; Shi et al. 2012; Cheng et al. 2013). Whether
TRPC proteins form a distinct family of SOCs remains
controversial because it is unclear how store depletion
couples to channel activation. However, there is growing
support for STIM1 also being involved in the activation
of TRPC-based SOCs through both Orai1-dependent and
independent mechanisms (Ambudkar et al. 2007; Worley
et al. 2007; Yuan et al. 2009; Cheng et al. 2011; Cheng et al.
2013; Liao et al. 2014).
It is proposed that VSMCs differentially express
Orai1-based CRACs and/or TRPC-based SOCs according
to their phenotype. In cells expressing a contra-
ctile phenotype, such as acutely isolated VSMCs and
primary cultured VSMCs maintained under low serum
conditions, SOCs have relatively linear rectification,
unitary conductances of 2 pS and are composed of a
heteromeric TRPC1/C5 molecular template that may also
contain other TRPC subunits (Saleh et al. 2008; Albert
et al. 2009; Large et al. 2009; Albert 2011; Shi et al.
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2012). Because TRPC1 is essential for conferring gating by
store depletion, these channels are termed TRPC1-based
SOCs (Shi et al. 2012). Importantly, SOCs with properties
similar to Orai1-based CRACs have not been described
in contractile VSMCs (Shi et al. 2012), and Orai proteins
are poorly expressed in these cells (Berra-Romani et al.
2008; Trebak, 2012). In contrast, long-term cultured
VSMCs maintained under high serum conditions, which
display a non-contractile, synthetic phenotype associated
with cell proliferation and migration, express both
TRPC1-based SOCs (Li et al. 2008; Ng et al., 2009,
2010) and Orai1-based CRACs (Potier et al. 2009; Li
et al. 2011; Beech, 2012; Trebak, 2012). In the present
study, we examined the activation mechanisms of native
TRPC1-based SOCs in contractile VSMCs that probably
mediate Ca2+ entry pathways involved in regulating
vascular tone and the switchingofVSMCs fromcontractile
to synthetic phenotypes (Matchkov et al. 2013).
Our previous findings have revealed that protein kinase
C (PKC) activity is pivotal for stimulation of TRPC1-based
SOCs in contractile VSMCs (Saleh et al. 2008; Albert et al.
2009; Large et al. 2009; Albert 2011; Shi et al. 2012). It
is proposed that store-operated PKC phosphorylation of
TRPC1 is necessary for PIP2 binding to occur, which
acts as the gating ligand (Saleh et al. 2009; Albert et al.
2009; Large et al. 2009; Albert 2011; Shi et al., 2012,
2014). This process is controlled by the PIP2-binding
protein myristoylated alanine-rich C kinase substrate,
which behaves as a reversible PIP2 buffer to control the
local PIP2 levels required for channel activation (Shi et al.
2014). In a recent study, we investigated how depletion
of stores induces this activation pathway and revealed
that storedepletion stimulatesGαq-evokedPLCβ1 activity
to induce PKC phosphorylation of TRPC1 proteins (Shi
et al. 2016). However, these studies did not determine how
store depletion is coupled toGαq/PLCβ1 activity. The pre-
sent study investigates this question, and identifies a new
activation mechanism of TRPC1-based SOCs in VSMCs,
as well as a novel role for STIM1, in which store depletion
induces the formation of STIM1-TRPC1 complexes that
stimulate PLC activity.
Methods
Cell isolation
New Zealand White rabbits (2–3 kg) were killed
using I.V. sodium pentobarbitone (120 mg kg−1) and
wild-type (WT) and TRPC1−/− mice were killed using
cervical dislocation according to UK Animals Scientific
Procedures Act of 1986 and as revised by European
Directive 2010/63/EU. All experiments were carried out
in accordance with guidelines laid down by St George’s,
University of London Animal Welfare Committee, and
conform with the principles and regulations described by
Grundy (2015). Portal veins from rabbit or second-order
mesenteric arteries from mice were dissected free, and
then cleaned of fat, connective tissue and endothelium
in physiological salt solution containing (mM): 126 NaCl,
6 KCl, 10 glucose, 11 Hepes, 1.2 MgCl2 and 1.5 CaCl2
(pH adjusted to 7.2 using 10 M NaOH). Vessels were
enzymatically dispersed into single VSMCs as described
previously (Shi et al. 2016).
Primary cell culture
VSMCs were seeded into culture plates; maintained
using Dulbecco’s modified Eagle’s medium/F-12 media
containing 1% serum, and incubated at 37°C in
95%O2:5%CO2 at 100% humidity for up to 7 days. In 1%
serum, VSMCs maintained their contractile phenotype
and had properties similar to TRPC1 channel currents in
freshly dispersed VSMCs (Shi et al. 2016), suggesting that
compensatory changes to channel properties probably did
not take place under these cell culture conditions.
Electrophysiology
Whole-cell and single-channel cation currents were
recorded with an AXOpatch 200B amplifier (Axon
Instruments, Union City, CA, USA) at room temperature
(20–23°C) as described previously (Shi et al. 2016).
Whole-cell currents were filtered at 1 kHz (−3 dB,
low-pass 8-pole Bessel filter, Frequency Devices model
LP02; Scensys, Aylesbury, UK) and sampled at 5 kHz
(Digidata 1322A and pCLAMP, version 9.; Molecular
Devices, Sunnydale,CA,USA).Whole-cell current/voltage
(I/V) relationships were obtained by applying 750 ms
duration voltage ramps from+100 to−150mV every 30 s
from a holding potential of 0 mV. Single-channel currents
were filtered between 0.1 and 0.5 kHz and acquired at
1–5 kHz. Single-channel I/V relationships were evaluated
by manually altering the holding potential of −80 mV
between −120 and +120 mV. Single-channel current
amplitudes were calculated from idealized traces of60 s
in duration using the 50% thresholdmethod and analysed
using pCLAMP, version 9.0. Events lasting for < 6.664 ms
(2 × rise time for a 100 Hz (−3 dB) low-pass filter)
were excluded from analysis to maximize the number of
channel openings reaching their full current amplitude.
Open probability (NPO) was used as a measure of channel
activity and was calculated automatically using pCLAMP,
version 9. Single-channel current amplitude histograms
wereplotted fromthe eventdataof the idealized traceswith
a bin width of 0.01 pA. Amplitude histograms were fitted
using Gaussian curves with peak values corresponding
to channel open levels. Mean channel amplitudes at
different membrane potentials were plotted, and I/V
relationships were fitted by linear regression with the
gradient determining conductance values. Images were
C© 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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prepared using Origin, version 6.0 (MicroCal Software,
Northampton,MA,USA), inwhich inward single-channel
openings are shown as downward deflections.
Whole-cell recording bath solution contained (mM):
126 NaCl, 1.5 CaCl2, 10 Hepes, 11 glucose, 0.1
4,4-diisothiocyanostilbene-2,2-disulphonic acid, 0.1
niflumic acid, and 0.005 nicardipine, pH to 7.2 with
NaOH. Under these conditions, voltage-dependent Ca2+
channels and Ca2+-activated and swell-activated Cl−
conductances are blocked, allowing cation conductances
to be recorded in isolation. Whole-cell patch pipette
and inside-out patch bathing solutions contained
(mM): 18 CsCl, 108 cesium aspartate, 1.2 MgCl2,
10 Hepes, 11 glucose, 1 Na2ATP and 0.2 NaGTP
(pH adjusted to 7.2 with Tris). Free [Ca2+]i was set
at 100 nM by adding 4.8 mM CaCl2 plus 10 mM
1,2-bis-(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic
acid(acetoxymethyl ester) (BAPTA)or 0.48mMCaCl2 plus
1 mM BAPTA for whole-cell and inside-out recordings
respectively using EqCal (Biosoft, Cambridge, UK). In
cell-attached patch experiments, the membrane potential
was set to 0 mV by perfusing cells in a KCl external
solution containing (mM): 126 KCl, 1.5 CaCl2, 10 Hepes
and 11 glucose (pH adjusted to 7.2 with 10 M KOH).
Nicardipine (5 μM) was included to prevent smooth
muscle cell contraction by blocking Ca2+ entry through
voltage-dependent Ca2+ channels. The patch pipette
solution used for both cell-attached and inside-out
patch recording (extracellular solution) was K+ free
and contained (mM): 126 NaCl, 1.5 CaCl2, 10 Hepes,
11 glucose, 10 TEA, 5 4-AP, 0.0002 iberiotoxin, 0.1
4,4-diisothiocyanostilbene-2,2-disulphonic acid, 0.1
niflumic acid and 0.005 nicardipine (pH adjusted to 7.2
with NaOH).
Knockdown of STIM1 and PLCβ1
We used lentiviral-mediated delivery of pLKO.1-puro
based short hairpin RNA (shRNA) expression plasmids
to knockdown STIM1 and PLCβ1 (Sigma-Aldrich,
Gillingham, UK). Infected VSMCs were selected with
2.5μgml−1 puromycin (Invitrogen, San Diego, CA, USA)
for 2 days prior to the experiments, and STIM1 andPLCβ1
levels were determined by western blotting. Two STIM1
shRNA were used to knockdown proteins in rabbits
(Sequence 1: 5′-CACCTTCCATGGTGAGGATAA-3′ and
Sequence 2: 5′-GGCTGCTGGTTTGCCTATATC-3′) and
twodifferent sequenceswereused toknockdownSTIM1 in
mice (Sequence 1: 5′-CACCTTCCATGGTGAGGATAA-3′
and Sequence 2: 5′-CCCTTCCTTTCTTTGCAATAT-3′).
PLCβ1 shRNA1 (5′-GCAGATAAACATGGGCATGTA-3′)
and shRNA2 (5′-GCTGTCTTTGTCTACATAGAA-3)
were used to knockdown PLCβ1 in both rabbits and mice
(Shi et al. 2016). Scrambled shRNAsequences fromSTIM1
shRNA1/2 and PLCβ1 shRNA1/2 were used as controls.
Imaging of GFP-PLCδ-PH-mediated signals
VSMCs were transfected with GFP-PLCδ-PH (plasmid
ID:21179; Addgene, Cambridge, MA, USA) using
Nucleofector in accordance with the manufacturer’s
instructions (Amaxa Biosystems, Gaithersburg, MD,
USA). Next, 0.2–0.4 μg of plasmid DNA was added to
1 × 105 cells re-suspended in 20 μl of Nucleofector
solution, and cells were kept in primary cell culture
conditions for up to 3 days. Transfected cells were imaged
using an LSM 510 laser scanning confocal microscope and
associated software (CarlZeiss, Jena,Germany). Excitation
was produced by 488/405 nm lasers and delivered via
an Apochromat 63× oil-immersion objective (numerical
aperture, 1.4) (Carl Zeiss). Two-dimensional images cut
horizontally through approximately themiddle of the cells
were captured (1024 × 1024 pixels). Final images were
produced using PowerPoint (Microsoft Inc., Redmond,
WA, USA).
Immunoprecipitation and western blotting
Freshly isolated vessel segments or primary cultured
cells were lysed by sonication for 3 h in RIPA buffer
(Santa Cruz Biotechnology, Santa Cruz, CA, USA) and
then transferred to a microcentrifuge tube and cleared
by centrifuging at 1000 g for 10 min at 4°C. Total
cell lysate protein was immunoprecipitated using anti-
bodies raised against targeted proteins with a Millipore
Catch and Release Kit (Millipore, Billerica, MA,
USA) followed by one-dimensional protein gel electro-
phoresis (15–20 μg of total protein/lane). Separated
proteins were transferred onto polyvinylidene difluoride
membranes, and then membranes were incubated with
5% (weight/volume) non-fat milk in PBS containing
0.1% Tween 20 to block non-specific binding, and then
primary antibodies were added and the membrane left
overnight at 4°C. Visualization was performed with a
horseradish peroxidase-conjugated secondary antibody
(80 ng ml−1) and ECL chemiluminescence reagents
(Pierce Biotechnology, Inc., Rockford, IL, USA) for
1 min and exposure to photographic films. Band
intensities were calculated using Image Studio software
(Li-Cor Biosciences Ltd, Cambridge, UK) and then were
normalized to control bands. Data shown represent the
findings obtained from3 different animals.
Immunocytochemistry
Freshly isolated VSMCs were fixed with 4%
paraformaldehyde (Sigma-Aldrich) for 10 min, washed
with PBS, and permeabilized with PBS containing 0.1%
Triton X-100 for 20 min at room temperature. Cells
were incubated with PBS containing 1% BSA for 1 h
at room temperature and then were incubated with
primary antibodies in PBS containing 1% BSA overnight
C© 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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at 4°C. In control experiments, cells were incubated
without the primary antibody. The cells were washed
and incubated with secondary antibodies conjugated to a
fluorescence probe. Unbound secondary antibodies were
removed by washing with PBS, and nuclei were labelled
with 4′,6-diamidino-2-phenylindole (DAPI) mounting
medium (Sigma-Aldrich). Cells were imaged using an
LSM 510 laser scanning confocal microscope (Carl Zeiss).
The excitation beam was produced by an argon (488 nm)
or helium/neon laser (543 nm and 633 nm) and delivered
to the specimen via an Apochromat 63× oil-immersion
objective (numerical aperture, 1.4) (Carl Zeiss). Emitted
fluorescence was captured using LSM 510 software
(release 3.2; Carl Zeiss). Two-dimensional images cut
horizontally through approximately the middle of the
cells were captured (1024 × 1024 pixels). Raw confocal
imaging data were processed and analysed using LSM 510
software. Final images were produced using PowerPoint
(Microsoft Inc.).
Proximity ligation assay
Freshly isolated VSMCs were studied using the Duolink
in situ proximity ligation assay (PLA) detection
kit 563 (Olink, Uppsala, Sweden) (Soderberg et al.
2008). Cells were adhered to coverslips, fixed in PBS
containing 4% paraformaldehyde for 15 min, and
permeabilized in PBS containing 0.1% Triton X-100
for 15 min. Cells were blocked for 1 h at 37°C
in blocking solution, and incubated overnight at 4°C
with anti-STIM1 and anti-TRPC1 antibodies (both
at dilution 1:200) in antibody diluent solution. Cells
were labelled with combinations of either anti-goat
PLUS/anti-rabbit MINUS or anti-goat PLUS/anti-mouse
MINUS depending on animal species used for 1 h
at 37°C. Hybridized oligonucleotides were ligated for
30 min at 37°C prior to amplification for 100 min
at 37°C. Red fluorescence-labelled oligonucleotides were
then hybridized to rolling circle amplification products,
and visualized using a Confocal LSM 510 (Carl Zeiss).
Reagents
Rabbit anti-TRPC1 antibody was generated by GenScript
(Piscataway, NJ, USA) using peptide sequences from
a previously characterized putative extracellular region
(Xu & Beech, 2001). Goat anti-TRPC1 (sc-15055),
mouse anti-STIM1 (sc-393705), goat anti-STIM1
(sc-79106), goat anti-TRPC6 (sc-19196), mouse anti-Gαq
(sc-136181), goat anti-PLCβ1 (sc-31755) and mouse
anti-PLCβ1 (sc-5291) antibodies were obtained from
Santa Cruz Biotechnology (Dallas, TX, USA). All
secondary antibodies were obtained from Santa Cruz
Biotechnology. Alexa fluor 488-conjugated donkey
anti-rabbit antibodies and Fluor 546-conjugated donkey
anti-mouse antibodies were obtained fromThermo Fisher
Scientific (Waltham, MA, USA). Mouse anti-β-actin anti-
body (A1978) was obtained from Sigma-Aldrich. Rabbit
anti-STIM1 antibody against the N-terminal EF hand
(11565-1-AP) was obtained from Proteintech (Chicago,
IL, USA), mouse anti-GOK/STIM1 (610954) against the
N-terminal EF hand was obtained from BD Biosciences
(Oxford,UK) andmouse anti-STIM1 antibody against the
C-terminal region (SC-66173) was obtained from Santa
Cruz. All other drugswere purchased fromSigma-Aldrich,
or Tocris (Abingdon, UK). Agents were dissolved in
distilled H2O or 0.1% DMSO. DMSO alone had no effect
on whole-cell currents or single-channel activity.
Statistical analysis
Statistical analysis was performed using paired
(comparing the effects of agents on the same cell) or
unpaired (comparing the effects of agents between cells)
Student’s t tests. P < 0.05 was considered statistically
significant.
Results
TRPC1 compose SOCs in contractile VSMCs
In our initial experiments, we confirmed that native
TRPC1-based SOCs are functionally expressed in
contractile VSMCs using freshly isolated mesenteric
artery VSMCs from WT and TRPC1−/− mice, and
antibodies raised against TRPC1 as channel blockers (Xu
& Beech, 2001; Xu et al. 2005; Saleh et al. 2008; Albert
et al. 2009; Large et al. 2009; Albert, 2011; Shi et al.
2012; Shi et al. 2016). In WT VSMCs, passive depletion
of internal Ca2+ stores following cell dialysis with a
patch pipette solution containing high concentrations
of BAPTA and no added Ca2+ evoked whole-cell
cation currents with a relatively linear current-voltage
(I/V) relationship and an Erev of +20 mV, which were
inhibited by bath application of TIE3, a TRPC1 antibody
raised against a putative extracellular channel pore site
(Xu & Beech, 2001; Xu et al. 2005), by >80% at all
membrane potentials tested (Fig. 1A). In WT VSMCs,
bath application of the cell-permeable Ca2+ chelator
1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic
acid acetoxymethyl ester (BAPTA-AM), also activated
single-channel activity in cell-attached patches with a
unitary conductance of 2 pS, which was inhibited by
bath application of an TRPC1 antibody raised against
an putative intracellular site by 85% at −80 mV
following patch excision into the inside-out configuration
(Fig. 1B). These whole-cell and single-channel current
properties are similar to those of native TRPC1-based
SOCs previously described in VSMCs from various
vascular beds and different animal species (Saleh et al.
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2008; Albert et al. 2009; Large et al. 2009; Albert, 2011;
Shi et al. 2012; Shi et al. 2016). In further agreement with
earlier findings, store-operated whole-cell conductances
and single-channel activities were absent in TRPC1−/−
VSMCs (Shi et al. 2012) (Fig. 1). These results clearly
indicate that native TRPC1-based SOCs are functionally
expressed in contractile VSMCs.
STIM1 is obligatory for activation of TRPC1 SOCs
We next examined whether STIM1 is involved in
activatingTRPC1-based SOCs in contractileVSMCsusing
a knockdown strategy, and an antibody raised against
the N-terminal EF hand of STIM1 (Spassova et al.
2006; Hewavitharana et al. 2008). Western blot studies
showed that STIM1 protein is expressed in primary
cultured rabbit portal vein VSMCs, maintained under low
concentrations of fetal calf serum to retain their contractile
phenotype (Shi et al. 2016), and that two different STIM1
shRNA sequences reduced STIM1 expression by 80%
compared to scrambled shRNA sequences (Fig. 2A). In
control experiments, STIM1 shRNA1didnot alterTRPC1,
Gαq, PLCβ1 and β-actin expression levels (data not
shown).
In VSMCs expressing scrambled shRNA, development
of store-operated whole-cell TRPC1 currents remained
unaffected, although peak currents were inhibited by
>80% at all membrane potentials tested following
bath application of the N-terminal STIM1 antibody
(Fig. 2B). Treatment of cells with STIM1 shRNAs
reduced development of store-operatedwhole-cell TRPC1
currents by about 60% at all membrane potentials tested
(Fig. 2B), and inhibitedBAPTA-AM-evoked single TRPC1
channel activities by >80% at −80 mV (Fig. 2C). In
addition, the SR Ca2+-ATPase inhibitor cyclopiazonic
acid (CPA) and the cell-permeable low affinity Ca2+
chelator N,N,N‘,N’-tetrakis(2-pyridylmethyl)ethane-1,2-
diamineed (TPEN) also activated TRPC1 channel
activities, which were reduced by STIM1 shRNA1 and 2
(datanot shown).These results clearly indicate that STIM1
is essential for activation of native TRPC1-based SOCs in
contractile VSMCs.
Store-operated PKC phosphorylation of TRPC1
requires STIM1
We have previously shown that PKC phosphorylation of
TRPC1 is a pivotal event in the activation of TRPC1-based
TRPC1−/−
TRPC1−/−
TRPC1−/−
TRPC1−/−
w.c.
50µM BAPTA-AM
1 μgml−1 T1E3
w.c.
60s 100 pA
50µM BAPTA-AM
1:200
TRPC1 ab
i/o 120s
0.4 pA
WT
A
0.0
c/
a i/o
TR
PC
1 
ab
0.2
0.4
0.6
0.8
1.0
N
P
o 
of
B
A
P
T
A
-A
M
-e
vo
ke
d
ch
an
ne
l a
ct
iv
ity
at
 −
80
 m
V
***
WT
B
WT
−50-100−150 10050
−10
−5
5
/ WT+TIE3
WT pA/pF
mV
Figure 1. TRPC1 compose SOCs in contractile VSMCs
A, development of a store-operated whole-cell current in a mesenteric artery VSMC from a WT mouse following
break-in into the whole-cell configuration (w.c.) was inhibited by bath application of T1E3. Vertical deflections
represent currents evoked by voltage ramps from +100 mV to −150 mV (750 ms duration) every 30 s from a
holding potential of 0 mV. Development of a store-operated whole-cell TRPC1 current was absent in a TRPC1−/−
VMSC.Mean I/V relationships of store-operated whole-cell currents demonstrate that T1E3 reduced store-operated
whole-cell currents at all membrane potentials tested inWT VSMCs and that store-operated currents were absent in
TRPC1−/− VSMCs (each point is at least n = 6). B, BAPTA-AM evoked single channel activity in a cell-attached patch
(c/a) held at −80 mV from a WT VSMC was maintained following patch excision into the inside-out configuration
(i/o). Bath application of an intracellular acting anti-TRPC1 antibody to the cytosolic surface of the inside-out patch
inhibited BAPTA-evoked channel activity. BAPTA-AM failed to activate channel activity in a cell-attached held at
−80 mV from a TRPC1−/− VSMC. Mean data of the inhibitory effect of the anti-TRPC1 antibody on BAPTA-evoked
channel activity. Note that channel activities were maintained on changing from cell-attached to inside-out patch
configurations (n = 7; ∗∗∗P < 0.001).
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SOCs in contractile VSMCs (Shi et al. 2016) and
therefore we investigated whether STIM1 is involved
in this gating pathway. Immunoprecipitation of iso-
lated vessel lysates with a mixture of anti-phosphorylated
serine and threonine antibodies followed by western
blotting with an anti-TRPC1 antibody showed that
TRPC1 proteins expressed low basal phosphorylation,
which was greatly increased following pre-treatment with
BAPTA-AM (Fig. 3). Expression of STIM1 shRNA1 and
shRNA2 sequences and coapplication of the PKC inhibitor
GF09203X greatly reduced BAPTA-AM-induced TRPC1
phosphorylation by >80% (Fig. 3). These findings clearly
indicate that STIM1 is required for PKC phosphorylation
of TRPC1 proteins by store depletion.
Store depletion induces PLCβ1 activity mediated
by STIM1 and TRPC1
In a recent study, we reported that store depletion
stimulates Gαq-evoked PLCβ1 activity, which drives
PKC activity and gating of native TRPC1-based SOCs
in contractile VSMCs (Shi et al. 2016). However, it
remains unclear how store depletion stimulates this
pathway. The above findings reveal that STIM1 is central
for store-operated PKC phosphorylation of TRPC1 and
channel activation and therefore we investigated whether
this ER/SR Ca2+ sensor couples store depletion to
stimulation of PLCβ1 activity. To monitor store-operated
PLCβ1 activity, we transfected primary cultured VSMCs
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Figure 2. TRPC1-based SOCs are dependent on STIM1
A, western blots and mean data confirm that two different STIM1 shRNA sequences (shRNA1 and shRNA2)
reduced STIM1 expression (three primary rabbit portal vein VSMC culture preparations; ∗∗P < 0.01). B, traces
and mean I/V relationships showing that peak amplitude of store-operated whole-cell TRPC1-based currents were
greatly reduced at all membrane potentials tested following transduction of rabbit portal vein VSMCs with shRNA
sequences compared to scrambled shRNA sequences. In the presence of scrambled sequences, store-operated
TRPC1-based currents were inhibited by an anti-STIM1 antibody (n = 6). C, recordings and mean data showing
that BAPTA-AM-evoked TRPC1-based SOCs were reduced by shRNA sequences targeting STIM1 compared to
scrambled shRNA in VSMCs (n = 6; ∗∗∗P < 0.001).
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with GFP-PLCδ1-PH, a fluorescence biosensor with a
high affinity for PIP2 and InsP3 (Balla & Vamai, 2009;
Szentpetery et al. 2009) and measured signal changes
(measured as relative fluorescence units) at the PM (Fm)
and within the cytosol (Fc) as described previously (Shi
et al. 2016).
In unstimulated VSMCs containing scrambled or
STIM1 shRNAs, GFP-PLCδ1-PH signals had a mean
Fm/Fc ratio of 7, reflecting a predominant location of
PIP2 at the PM (Fig. 4A). In scrambled shRNA VSMCs,
bath application of BAPTA-AM produced a significant
reduction in the mean Fm/Fc ratio. This GFP-PLCδ1-PH
signal change represents PLCβ1 activity stimulated by
store depletion causing PIP2 hydrolysis at the PM and the
subsequent generation of cytosolic InsP3 as described pre-
viously (Balla & Vamai, 2009; Szentpetery et al. 2009; Shi
et al. 2016). In further agreement with our earlier study
(Shi et al. 2016), BAPTA-AM-induced GFP-PLCδ1-PH
signal changes were inhibited by coapplication the PLC
inhibitor U73122 (Fig. 4A). Similar effects onmean Fm/Fc
ratio were also produced with CPA and TPEN (data not
shown).
Knockdown of STIM1 with shRNA1 and shRNA2
sequences greatly reduced translocation of GFP-
PLCδ1-PH signals induced by BAPTA-AM (Fig. 4B and
C) and CPA and TPEN (data not shown), indicating
that STIM1 is the probable mediator that stimulates PLC
activity when stores are depleted by BAPTA-AM, CPA or
TPEN.
Stimulation of endogenously expressed α1 Gαq-
coupled adrenoreceptors by bath application of
noradrenaline induced translocation of GFP-PLCδ1-PH
signals fromthePMto the cytosol in thepresenceof STIM1
shRNA1 and 2 (Fig. 4B and C). These results indicate
that STIM1 independent pathways have a dominant
role in stimulating PLC activity by this concentration
of noradrenaline, and that knockout of STIM1 per se
does not prevent activation of PLC. These findings do
not exclude the possibility that noradrenaline-stimulated
STIM1 activity produces a small contribution to overall
PLC activity, which is sufficient to activate TRPC1-based
SOCs (see Fig. 11 and accompanying text).
Because our findings indicate that STIM1 is obligatory
for activation of TRPC1-based SOCs and store-operated
PLC activity but is not required for PLC activity per
se, we investigated whether TRPC1 is also essential for
coupling store depletion to stimulation of PLC activity.
In VSMCs from WT mice, BAPTA-AM evoked a trans-
location of GFP-PLCδ1-PH signals from the PM to the
cytosol similar to those in rabbit VSMCs (Fig. 4A) and
these signal changes were also reduced by coapplication
of U73122 (Fig. 5A). By contrast, BAPTA-AM failed to
alter the cellular distribution of GFP-PLCδ1-PH signals in
TRPC1−/− VSMCs, although noradrenaline was capable
of evoking substantial translocation of GFP-PLCδ1-PH
signals (Fig. 5B). Similar effects between WT and
TRPC1−/− micewere producedwith CPA andTPEN (data
not shown). These data suggest that TRPC1, similar to
STIM1, is an important determinant for store-operated
PLC activity but it is not an absolute requirement for
Gαq-coupled receptor-stimulated PLC activity.
Store depletion induces interactions between STIM1,
TRPC1, Gαq and PLCβ1
The present study proposes that both STIM1 and TRPC1
are required for store depletion to stimulate PLCβ1
activity, and thereforewehypothesized that storedepletion
probably induces associations between STIM1 andTRPC1
at (or near) the PM.
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Figure 3. Store-operated phosphorylation of TRPC1 proteins requires STIM1
A, co-immunoprecipitation of rabbit portal vein tissue lysates with anti-phosphorylated serine (pSer) and threonine
(pThr) antibodies followed by western blotting (WB) with an anti-TRPC1 antibody shows that basal TRPC1
phosphorylation is increased by pre-treatment with BAPTA-AM for 10 min, and that this increase was reduced by
STIM1 shRNA1 and coapplication of GF109203X. B, mean relative band densities normalized to BAPTA-AM
bands (three different tissue lysate preparations; ∗P < 0.05, ∗∗P < 0.01). [Colour figure can be viewed at
wileyonlinelibrary.com]
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In freshly isolated unstimulated VSMCs, immuno-
cytochemical studies showed that STIM1 staining (red)
was mainly located within the cytosol, TRPC1 staining
(green) was predominantly found at the PM, and there
were sparse apparent regions of co-localization (Fig. 6A).
Pre-treatment with BAPTA-AM caused translocation of
STIM1 signals from the cytosol to the PM, and also
stimulated co-localizations between TRPC1 and STIM1
(yellow) at puncta-like sites (Fig. 6B). Moreover, PLA
studies showed no apparent signals between STIM1
and TRPC1 in unstimulated VSMCs, whereas robust
fluorescence signals (red) were found at the PM following
pre-treatment with BAPTA-AM (Fig. 6C and D). These
findings clearly indicate that store depletion stimulates
formation of STIM1-TRPC1 complexes at the PM. Inter-
estingly, in TRPC1−/− VSMCs, BAPTA-AM caused the
translocation of STIM1 signals to the PM, which had
a relatively even distribution without obvious discrete
puncta-like formation (Fig. 6E).
Because Gαq/PLCβ1 activity is obligatory for TRPC1
channel activation in VSMCs (Shi et al. 2016),
we next proposed that store-operated STIM1-TRPC1
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Figure 4. Store-operated PLC activity is mediated by STIM1
A, image from a single rabbit portal vein VSMC showing that in control conditions the location of
GFP-PLCδ1-PH-mediated signals (measured as relative fluorescence units; RFU) was predominantly expressed at
the PM (black). In the same cell, pre-treatment with BAPTA-AM for 10 min induced translocation of signals to the
cytosol (blue), and coapplication of U73122 for 5 min reversed these cytosolic signals back to the PM (orange).
Graphs of RFU of line scans for the region denoted along the white dotted lines show GFP-PLCδ1-PH signals
across the cell width. Mean Fm/Fc ratios of GFP-PLCδ1-PH-mediated signals represent 20 cells from three different
experiments (∗∗∗P<0.001). B and C, images and mean data showing that transduction of rabbit portal vein VSMCs
with either STIM1 shRNA1 or shRNA2 sequences prevented BAPTA-AM inducing translocation of GFP-PLCδ1-PH
signals to the cytosol. Under both these conditions, application of noradrenaline for 5 min (red, applied in the
presence of 1 μM Wortmannin to prevent cell contraction) was still able to induce translocation of GFP-PLCδ1-PH
signals from the PM to the cytosol (20 cells for each STIM1 shRNA sequence from three different experiments;
∗∗∗P < 0.01).
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complexes probably also encompass Gαq and PLCβ1.
In unstimulated primary cultured VSMCs expressing
scrambled shRNA, co-immunoprecipitation studies
showed that TRPC1 did not associate with STIM1,
Gαq or PLCβ1 (Fig. 7A). However, pre-treatment with
BAPTA-AM induced significant interactions between
these molecules (Fig. 7A). Similar interactions between
TRPC1 and STIM1 were also obtained with CPA
(data not shown). Knockdown of STIM1 with STIM1
shRNA1 significantly decreased BAPTA-AM-stimulated
associations between TRPC1 and STIM1, Gαq and PLCβ1
(Fig. 7A and B). Correspondingly, BAPTA-AM-activated
interactions between STIM1 and TRPC1, Gαq and PLCβ1
measured using co-immunoprecipitation (Fig. 7D) and
PLA (Fig. 8) were present in WT but absent in TRPC1−/−
cell lysates.
In control experiments, BAPTA-AM and CPA did not
alter expression levels of TRPC1, STIM1, Gαq and PLCβ1
(Shi et al. 2016), TRPC1 expression was not altered in the
presence of shRNA STIM1, and STIM1 expression was
not changed inWT and TRPC1−/− vessel lysates (data not
shown).
TRPC6 subunits form receptor-operated Ca2+-
permeable cation channels inVSMCs that arenot activated
by store depletion (Abramowitz & Birnbaumer, 2009;
Large et al. 2009; Albert, 2011; Earley & Brayden, 2015).
In accordance with these findings, we found that TRPC6
proteins were not associated with STIM1 at rest or
following pre-treatment with BAPTA-AM in vessel lysates
(Fig. 7C).
Taken together, these results suggest that store-operated
formation of STIM1-TRPC1 complexes is required before
interactions with Gαq and PLCβ1 occur. To further
explore this idea, we studied the effect of decreasing
expression of PLCβ1 on store-operated interactions
between TRPC1 and STIM1. In VSMCs expressing
scrambled shRNA, PLA studies showed that BAPTA-AM
induced interactions between TRPC1 and PLCβ1, and
STIM1 (Fig. 9A and C). However, in the presence
of PLCβ1 shRNA1 and 2, BAPTA-AM-evoked inter-
actions between TRPC1 and PLCβ1 were greatly reduced,
whereas association betweenTRPC1 and STIM1 remained
unaffected (Fig. 9B and C). Similar results following
expression of PLCβ1 shRNA1 and 2 were obtained
for BAPTA-AM-induced interactions between TRPC1
and PLCβ1, and STIM1 using co-immunoprecipitation
(Fig. 9D and E). In control experiments, PLCβ1 shRNA1
and 2 did not alter expression of TRPC1, Gαq and STIM1
(data not shown).
STIM1 acts as a cell surface transmembrane protein
to activate TRPC1-based SOCs
In the present study, we have shown that application
of the N-terminal EF hand STIM1 antibody to the
extracellular surface of VSMCs inhibited store-operated
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Figure 5. Store-operated PLC activity requires TRPC1
A, WT mesenteric artery VSMCs: application of BAPTA-AM for 10 min induced translocation of
GFP-PLCδ1-PH-mediated signals from the PM to the cytosol which was prevented by coapplication of U73122 for
5 min (20 cells from three different experiments; ∗∗∗P < 0.001). B, TRPC1−/− VSMCs: BAPTA-AM did not alter the
cellular distribution of GFP-PLCδ1-PH signals whereas application of noradrenaline for 5 min induced translocation
of GFP-PLCδ1-PH signals from the PM to the cytosol (20 cells from three different experiments; ∗∗∗P < 0.001).
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TRPC1-based SOCs (Fig. 2B). This raises the possibility
that store depletion may induce translocation of STIM1
from the intracellular compartment to the PM where it
acts a transmembrane protein to interact with TRPC1
and stimulate PLCβ1 activity. To further investigate this
idea, we compared the effect of the N-terminal STIM1
antibody with an antibody raised against a C-terminal
region of STIM1 (Prakriya & Lewis, 2015) on activation of
TRPC1-based SOCs and on store-operated translocation
of STIM1 from the cytoplasm to the PM.
In freshly isolated WT VSMCs, bath application of
the N-terminal STIM1 antibody greatly reduced the
mean amplitude of store-operated whole-cell currents
from 4.6 ± 0.8 pA/pF to 1.6 ± 0.4 pA/pF (n = 6)
at −80 mV but had little effect on BAPTA-AM-evoked
single-channel activity when bath applied to the
cytosolic surface of inside-out patches (Fig. 10A and B).
By contrast, bath application of the C-terminal STIM1
antibody had little effect on store-operated whole-cell
currents but produced pronounced inhibition of the
mean NPo value of BAPTA-AM-evoked single-channel
activity from 0.63 ± 0.05 to 0.13 ± 0.02 (n = 6)
at −80 mV when applied to the cytosolic surface of
inside-outpatches (Fig. 10A andB). Immunocytochemical
studies also revealed differential effects of N-terminal
and C-terminal STIM1 antibodies on STIM1 staining
according towhether cells were permeabilizedwith Triton.
In unstimulatedVSMCs,N-terminal andC-terminal anti-
bodies only produced staining for STIM1 when cells
were treated with Triton (Fig. 10C and D). However,
BAPTA-AM-evoked translocation of STIM1 signals to
the PM were recorded using the N-terminal STIM1
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Figure 6. Store-depletion induces co-localizations between STIM1 and TRPC1 at the PM
A and B, images from two different rabbit portal vein VSMCs showing TRPC1 (green) and STIM1 (red) staining.
Changes in the relative fluorescence of TRPC1 and STIM1 staining across the cell width were determined from the
line scan (dotted white line). In a resting cell (A), TRPC1 staining was predominantly present at the PM, whereas
labelling for STIM1 was located within the cytosol. In a cell treated with BAPTA-AM for 10 min (B), both TRPC1 and
STIM1 were located at the PM in discrete puncta. Inset: co-localization between TRPC1 and STIM1 staining (yellow)
at the PM. C andD, PLA images showing BAPTA-AM induced fluorescence signals between STIM1 and TRPC1which
were predominantly at the PM in rabbit portal vein and mice mesenteric artery VSMCs. E, immunocytochemical
image showing that, in TRPC1−/− mesenteric artery VSMCs, BAPTA-AM induced translocation of STIM1 from the
cytosol to the PM where it produced uniform, non-puncta-like staining.
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antibody in both Triton and non-Triton treated VSMCs,
whereas BAPTA-AM-evoked STIM1 translocation to the
PM was only recorded with the C-terminal STIM1
antibody in cells pre-treated with Triton (Fig. 10C
and D).
These findings further indicate that, in resting cells,
STIM1 is probably found within the cell not the
PM. Furthermore, activation of TRPC1-based SOCs
by STIM1 may involve store-operated STIM1 trans-
location to the PM where it acts as a transmembrane
protein, with its N-terminal region exposed to the
extracellular environment and its C-terminal remaining
within the cytosol. It is perhaps in this configuration that
TRPC1-STIM1 interactions stimulate PLC activity.
Noradrenaline-evoked TRPC1 activation requires
STIM1
The results of the present study clearly demonstrate
that STIM1 is critical for stimulation of native TRPC1
channels by agents that deplete internal Ca2+ stores. In
a final series of experiments, we investigated whether
STIM1 is involved in activation of TRPC1 channels by the
vasoconstrictor noradrenaline. In WT VSMCs expressing
scrambled shRNA, bath application of noradrenaline
activated 2 pS TRPC1 channel activity in cell-attached
patches held at −80 mV in a concentration-dependent
manner asdescribedpreviously (Shi et al.2016). In thepre-
sence of STIM1 shRNAs, stimulation of TRPC1 channel
activities by concentrations of noradrenaline >1 μM were
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Figure 7. Store-depletion evokes associations between TRPC1, STIM1, Gαq and PLCβ1
A, western blots showing that pre-treatment with BAPTA-AM for 10 min induced associations between TRPC1
and STIM1, Gαq and PLCβ1, which were reduced by STIM1 shRNA1. Primary cultured rabbit portal vein VSMC
lysates were initially immunoprecipitated (IP) with anti-TRPC1 antibodies and were then western blotted (WB) with
anti-STIM1, anti-Gαq or anti-PLCβ antibodies. B, mean data for relative band intensities of BAPTA-AM-evoked
interactions with TRPC1 shown in A (three different cell lysates; ∗P < 0.05). C, application of BAPTA-AM for
10 min did not alter interactions between TRPC6 and STIM1 (left) or change expression levels of TRPC6 (right) in
rabbit portal vein tissue lysates. D, primary cultured WT mesenteric artery VSMCs: BAPTA-AM evoked interactions
between STIM1 and TRPC1, Gαq and PLCβ1, which were absent in cell lysates from TRPC1−/− VSMCs.
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reduced by >80% (Fig. 11A and B). In PLA experiments,
noradrenaline induced interactions between STIM1 and
TRPC1, Gαq and PLCβ1 (Fig. 11C). These results strongly
suggest that STIM1 is required for activation of native
TRPC1 channel activity by noradrenaline.
Discussion
The present study reveals that, in contractile VSMCs,
depletion of intracellular Ca2+ stores causes STIM1 to
translocate from within the cell to the PM where it inter-
acts with TRPC1 to induce channel opening through
stimulation of Gαq-evoked PLCβ1 activity. In other cell
types, STIM1 has been proposed to combine directly
with TRPC-based SOCs and Orai1-based CRACs to cause
channel opening (Worley et al. 2007; Yuan et al. 2009;
Lee et al. 2014; Asannov et al. 2015; Prakriya & Lewis,
2015) and therefore these findings represent a novel
activation pathway of TRPC1-based SOCs and a pre-
viously unrecognized role for STIM1.
TRPC1-based SOCs require STIM1 for activation in
contractile VSMCs
We show that several well-established store depletion
protocols activate whole-cell conductances with a
relatively linear I/V relationship and an Erev of +20 mV
and single-channel currents with a unitary conductance
of 2 pS, which are inhibited by TRPC1 antibodies
and absent in TRPC1−/− VSMCs. Knockdown of STIM1
using two STIM1 shRNA sequences and two antibodies
raised against N- and C-terminal regions of ER/SR Ca2+
store sensor STIM1 also produced pronounced inhibition
of these store-operated whole-cell and single-channel
currents. These antibodies probably have a selective action
because they identify a protein band with a molecular
weight corresponding to STIM1, which has a reduced
density in the presence of shRNA STIM1. In addition, the
N-terminal STIM1 antibody has been shown to reduce
STIM1-evoked Icrac (Spassova et al. 2006). Knockdown of
STIM1 also reduced store-operated PKC phosphorylation
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Figure 8. Store-operated induced interactions between STIM1, Gαq and PLCβ1 require TRPC1
A, PLA images from WT mesenteric artery VSMCs showing that BAPTA-AM induced interactions between STIM
and Gαq, and also between STIM1 and PLCβ1. B, BAPTA-AM-evoked interactions between STIM and Gαq, and
STIM1 and PLCβ1 were absent in TRPC1−/− VSMCs.
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of TRPC1, which is a known pivotal event for activation
of TRPC1-based SOCs in contractile VSMCs (Saleh et al.
2008; Albert et al. 2009; Large et al. 2009; Albert 2011;
Shi et al. 2012). These findings confirm earlier reports
that native TRPC1-based SOCs are expressed in contra-
ctile VSMCs (Saleh et al. 2008; Albert et al. 2009; Large
et al. 2009; Albert 2011; Shi et al. 2012) and highlight, for
the first time, that STIM1 is an obligatory molecule in the
PKC-mediated gating pathway of these channels.
Store-operated STIM-TRPC1 interactions stimulate
PLCβ1 activity
There is substantial evidence that PKC activity is essential
for stimulation of TRPC1-based SOCs in contractile
VSMCs (Saleh et al. 2008; Albert et al. 2009; Large et al.
2009; Albert 2011; Shi et al. 2012) and, in a recent
study, we reported that store depletion stimulates Gαq-
evoked PLCβ1 activity to drive PKC activity and channel
opening (Shi et al. 2016). We therefore hypothesized
that, because STIM1 is an ER/SR Ca2+ sensor, its role in
activating TRPC1-based SOCs may be through coupling
store depletion to stimulation of Gαq/PLCβ1 activity.
Store-operated PLC activity recorded using the
PIP2/InsP3 biosensor GFP-PLCδ1-PH (Balla & Vamai,
2009; Szentpetery et al. 2009; Shi et al. 2016) was
inhibited by knockdown of STIM1, and was absent in
TRPC1−/− VSMCs, which indicates that both STIM1 and
TRPC1 are required to stimulate PLC activity. Immuno-
cytochemical and PLA studies identified that store
depletion stimulated the translocation of STIM1 from
within the cell to the PM, where it formed STIM1-TRPC1
complexes with puncta-like distributions. The discrete
pattern of STIM1-TRPC1 complex distribution appeared
to be dependent on TRPC1 because relatively even,
non-puncta-like STIM1 staining was produced by store
depletion in TRPC1−/− cells. In further agreement
with STIM1-TRPC1 complexes stimulating Gαq/PLCβ1
activity, co-immunoprecipitation studies revealed that
store depletion activate associations between TRPC1 and
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Figure 9. Store-operated interactions between TRPC1 and STIM1 do not require PLCβ1
A–C, application of BAPTA-AM for 10 min induced interactions between TRPC1 and PLCβ1 in rabbit portal
vein VSMCs measured using PLA that were reduced by expression of PLCβ1 shRNA1 and shRNA2 sequences,
whereas associations between TRPC1 and STIM1 were unaffected (three different preparations; ∗P < 0.05). D
and E, BAPTA-AM-induced interactions between TRPC1 and PLCβ1 measured using co-immunoprecipitation were
reduced by expression of PLCβ1 shRNA1 and shRNA2 sequences, whereas associations between TRPC1 and STIM1
were unaffected (three different rabbit portal vein cell lysates; ∗P < 0.05).
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Gαq, and PLCβ1, as well as between STIM1 and Gαq, and
PLCβ1, with these interactions requiring both STIM1 and
TRPC1. Knockdown of PLCβ1 did not affect formation
of store-operated STIM1-TRPC1 interactions, which
further implies that STIM1-TRPC1 interactions occur
before Gαq/PLCβ1 binding. It is not yet known whether
store-operated STIM1-TRPC1 interactions require Gαq
subunits, and whether association and stimulation of Gαq
and PLCβ1 activities occur with STIM1-TRPC1 inter-
actions in a sequential pathway.
Store depletion failed to induce interactions between
STIM1 and TRPC6, which forms non-TRPC1 containing
receptor-operated Ca2+-permeable channels in VSMCs
that are not activated by store depletion (Large et al.
2009; Albert, 2011). This agrees with over-expression
studies showing that store depletion activates inter-
actions between STIM1 and TRPC1-, TRPC4- and
TRPC5-based SOCs but does not stimulate interactions
between STIM1 and TRPC3, TRPC6 and TRPC7 that
are not activated by store depletion (Worley et al. 2007).
Thus, interactions with STIM1 are probably key in
determiningwhetherTRPCchannels are activated by store
depletion.
STIM1 has diverse cellular partners including ion
channels such as Orai1 channels (Prakriya & Lewis, 2015),
TRPC channels (Cheng et al. 2013), voltage-gated Ca2+
channels (Park et al. 2010; Wang et al. 2010), SR and PM
Ca2+-ATPases (Jousset et al. 2007; Ritchie et al. 2012),
and adenylyl cyclases (Lefkimmiatis et al. 2009). The
present study makes an important addition to this list:
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Figure 10. Differential actions of antibodies raised against N-terminal and C-terminal regions of STIM1
on activation of TRPC1-based SOCs
A, original trace showing that a store-operated whole-cell current from aWTmesenteric artery VSMCwas inhibited
by bath application of a N-terminal but not a C-terminal STIM1 antibody. B, representative recording showing
that BAPTA-AM-evoked single channel activity in an inside-out patch from a WT VSMC held at −80 mV was
inhibited by bath application of a C-terminal but not a N-terminal STIM1 antibody. C, representative images
from two different VSMCs treated with Triton, in which both N-terminal and C-terminal STIM1 antibodies WT
identified translocation of STIM1 signalling (red) from the cytosol to the PM following treatment with BAPTA-AM
for 10 min. D, representative images from two different WT VSMCs not treated with Triton, in which N-terminal,
nor C-terminal STIM1 antibodies identified STIM1 staining in unstimulated cells, and only the N-terminal antibody
revealed STIM1 staining at the PM following treatment with BAPTA-AM.
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store-operated formation of STIM1-TRPC1 complexes
that stimulate Gαq/PLCβ1 activity.
STIM1 acts at the PM to activate TRPC1 channels
It is not clear how store-operated STIM1-TRPC1 inter-
actions induce Gαq/PLCβ1 activity. Over-expression
studies generally indicate that activation of Orai1-based
CRACs and TRPC-based SOCs by STIM1 involves
movement of the ER membrane containing activated
STIM1 towards the PM, where junction-like complexes
are formed and STIM1 binds to intracellular domains
of channel proteins to assemble Orai1-based CRACs by
protein–protein interactions (Prakriya & Lewis, 2015) and
directly gate TRPC1-based SOCs using electrostatic and
protein–protein interactions (Worley et al. 2007; Yuan
et al. 2009; Lee et al. 2014; Asannov et al. 2015). Although
electrostatic gating is unique to TRPC1, protein–protein
interactions between STIM1 and CRAC and STIM1 and
TRPC1 channels involve the same 100 amino acid stretch
of STIM1 referred to as SOAR or CAD (Asannov et al.
2015). STIM1 has also been suggested to act at, or within,
the PM to activate Orai1-based CRACs (Zhang et al.
2005; Spassova et al. 2006; Hewavitharana et al. 2008) and
constitutively active STIM1 present in the PM is proposed
to be required for activation of arachidonic acid-regulated
Ca2+ channels composed of Orai1 and Orai3 subunits
(Thomson & Shuttleworth, 2013).
Our findings of differential inhibitory actions of
N- and C-terminal STIM1 antibodies on activation of
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Figure 11. Noradrenaline-evoked TRPC1 channel activity is mediated by STIM1
A, bath application of noradrenaline evoked TRPC1 channel activity in a concentration-dependent manner in
cell-attached patches fromWTmesenteric artery VSMCs held at−80mV, which were reduced in VSMCs expressing
STIM1 shRNA1 and shRNA2 sequences compared to scrambled shRNA. B, mean data showing the inhibitory actions
of STIM1 shRNA1 and shRNA2 on noradrenaline-evoked TRPC1 channel activity (at least six patches in which every
concentration of noradrenaline tested was cumulatively applied; ∗∗P < 0.01, ∗∗∗P < 0.001). C, PLA images from
single WT VSMCs showing that application of noradrenaline for 5 min induced fluorescence signals (red), which
indicated interactions between TRPC1 and STIM1, STIM1 and Gαq, and STIM1 and PLCβ1 predominantly at the
PM.
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TRPC1-based SOCs suggest that, in contractile VSMCs,
store-operated STIM1 is translocated from the SR into the
PM.Here, it probably continues to act as a transmembrane
protein through its proposed transmembrane domain
located between amino acids 214 and 234 (Soboloff
et al. 2012), with its N-terminal region presented to
the extracellular environment and its C-terminal region
remaining within the cell. It is in this configuration
that STIM1 probably forms complexes with TRPC1 that
allow subsequent binding and stimulation of Gαq/PLCβ1
activity. These conclusions indicate that STIM1 involved
in interacting with TRPC1 and stimulating Gαq/PLCβ1
activity is derived from within the cell, and is not
part of STIM1 pools constitutively present in the PM.
Future experiments are needed to examinine whether pre-
viously identified interactions sites between STIM1 and
TRPC1 (Worley et al. 2007; Yuan et al. 2009; Lee et al.
2014; Asannov et al. 2015) are involved in association
with Gαq and PLCβ1. Understanding the associations
between STIM1-TRPC1 andGαq subunits are particularly
important because these are probably the trigger for
initiating PLCβ1 activity that drives channel gating.
Involvement of Orai proteins involved in the
composition and activation of TRPC1-based SOCs
in contractile VSMCs
There is debate concerning whether functional TRPC-
based SOCs require involvement of Orai proteins, which
may act as pore-forming subunits or obligatory accessory
proteins, or may mediate Ca2+ signals that regulate
TRPC expression at the PM (Cheng et al. 2011; Cheng
et al. 2013; Liao et al. 2014; Prakriya & Lewis, 2015).
In synthetic, non-contractile VSMCs, store depletion
stimulates Ca2+ entry involving both TRPC1 and Orai1,
and also activates a conductance with Icrac-like properties
(Li et al. 2008; Ng et al., 2009, 2010; Li et al. 2011; Beech,
2012; Trebak, 2012). In contractile VSMCs, the present
study failed to detect store-operated conductances with
characteristics of Orai1-, Orai2- and Orai3-based SOCs
such as strong inward rectification and an Erev >+50 mV
(Lis et al. 2007; Prakriya & Lewis, 2015) in TRPC1−/−
VSMCs, and in WT cells when TRPC1-based SOCs were
inhibited with a TRPC1 antibody. This indicates that
Orai proteins probably do not contribute to activation
of TRPC1-based SOCs in contractile VSMCs, which is
in agreement with a low level of Orai protein expression
in these cells (Berra-Romani et al. 2008; Trebak, 2012).
In a wider context, this present study provides further
evidence that cells express multiple SOCs composed of
TRPC-based SOCs and Orai-based CRACs, which can
exist independently of one another.
It is possible that Orai-based CRACs are present in
contractile VSMCs but that opening of these channels
produces small irresolvable conductances using electro-
physiological techniques. An alternative approach may
be to investigate whether Orai-based Ca2+ sparklets
are present using total internal reflection fluorescence
Gαq receptor-coupled agonists,
SERCA inhibitors, Ca2+ chelators
Store-refilling, contraction,
proliferation, migration
PLCβ1
Gαq
TRPC1
A B
P
IP3
DAG
PKCPIP2 PLCβ1
Gαq
C
Resting Cells
Gαq
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Figure 12. Proposed activation model of TRPC1-based SOCs in contractile VSMCs
A, in resting VSMCs SR stores are filled with Ca2+, TRPC1-based SOCs do not interact with Gαq, PLCβ1 or STIM1,
and the channels are in a closed state. B, following store depletion of the SR, STIM1 proteins (red) are activated and
translocated from the SR into the PM, where they interact with TRPC1. Following translocation, the N-terminal EF
hand of STIM1, which acts as a Ca2+ sensor within the SR, is exposed on the external surface of the cell, whereas
the C-terminal region is maintained within the cytosol. C, formation of store-operated STIM1-TRPC1 interactions
enable the binding of Gαq and PLCβ1, which stimulate PLC activity, leading to PIP2 hydrolysis, formation of DAG,
PKC stimulation, phosphorylation of TRPC1 subunits and channel opening.
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microscopy, which can detect Ca2+ entry through opening
of Ca2+-permeable channels at localized regions of the
PM (Sonkusare et al. 2012). It is clear that a detailed
comparison on the role of Orai proteins in activation of
native TRPC1-based SOCs in contractile and synthetic
VSMCs is needed.
Physiological importance of STIM1-activated TRPC1
channels
TRPC1 channel activity induced by the endogenous
α1 adrenergic Gαq-coupled receptor agonist and vaso-
constrictor noradrenalinewas prevented by knockdownof
STIM1. Noradrenaline also evoked interactions between
TRPC1 and STIM1, STIM1 and Gαq, and STIM1 and
PLCβ1 at the PM. These results indicate that STIM1 is
important for activation of TRPC1 channels by a physio-
logically agonist, and suggests that this may involve a
similar activation pathway induced by agents that deplete
Ca2+ stores. This is further highlighted by previous
data showing that noradrenaline-evoked TRPC1 channel
activity is also inhibited by knockdownof PLCβ1 (Shi et al.
2016).
Physiological vasoconstrictors acting through Gαq-
coupled receptors stimulate PLC, leading to InsP3-
mediated depletion of Ca2+ stores and DAG-mediated
PKC activation. It therefore might be expected that the
store-operated STIM1/PLCβ1/PKC pathway described in
the present study represents a feed forward mechanism
to induce TRPC1 channel opening. However, our data
indicate that STIM1 and PLCβ1 contribute little to
overall PLC activation by noradrenaline (Figs 4B and
C and 5B) (Shi et al. 2016). This may suggest that
the STIM1/PLCβ1/PKC pathway involved in activating
TRPC1 channels is uniquely stimulated following store
depletion. To confirm these ideas, it will be important to
determine which PLC isoform is coupled to stimulation
of α1 Gαq-coupled adrenoreceptors, and also to identify
whether Gαq receptor/PLC-coupled DAG generation
activates a PKC isoform different from that induced
by store-operated PLCβ1 activity. Moreover, these ideas
should be tested using different vasoconstrictor agents
such as angiotensin II and endothelin-1, which are known
to stimulate TRPC1-based SOCs (Albert et al. 2009; Large
et al. 2009).
Conclusions
The present study describes a novel activation pathway
of TRPC1-based SOCs in native contractile VSMCs
(Fig. 12). Store depletion stimulates translocation of
STIM1 from the SR to the PM where it is inserted
as a transmembrane protein and forms STIM1-TRPC1
complexes, which subsequently bind and stimulation of
Gαq/PLCβ1 activities. This increase in PLCβ1 activity
stimulates channel opening through DAG-evoked PKC
phosphorylation of TRPC1.
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